These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 16377754)

  • 21. Distribution of heparan sulfate and dermatan sulfate in mucopolysaccharidosis type II mouse tissues pre- and post-enzyme-replacement therapy determined by UPLC-MS/MS.
    Menkovic I; Lavoie P; Boutin M; Auray-Blais C
    Bioanalysis; 2019 Apr; 11(8):727-740. PubMed ID: 30994022
    [No Abstract]   [Full Text] [Related]  

  • 22. Glycosaminoglycans analysis in blood and urine of patients with mucopolysaccharidosis.
    Khan SA; Mason RW; Giugliani R; Orii K; Fukao T; Suzuki Y; Yamaguchi S; Kobayashi H; Orii T; Tomatsu S
    Mol Genet Metab; 2018 Sep; 125(1-2):44-52. PubMed ID: 29779903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-performance liquid chromatographic/mass spectrometric studies on the susceptibility of heparin species to cleavage by heparanase.
    Bisio A; Mantegazza A; Urso E; Naggi A; Torri G; Viskov C; Casu B
    Semin Thromb Hemost; 2007 Jul; 33(5):488-95. PubMed ID: 17629845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of oversulfation in biglycan chondroitin/dermatan sulfate oligosaccharides by chip-based nanoelectrospray ionization multistage mass spectrometry.
    Flangea C; Sisu E; Seidler DG; Zamfir AD
    Anal Biochem; 2012 Jan; 420(2):155-62. PubMed ID: 22001376
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The binding properties of minimal oligosaccharides reveal a common heparan sulfate/dermatan sulfate-binding site in hepatocyte growth factor/scatter factor that can accommodate a wide variety of sulfation patterns.
    Deakin JA; Blaum BS; Gallagher JT; Uhrín D; Lyon M
    J Biol Chem; 2009 Mar; 284(10):6311-21. PubMed ID: 19114710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. (1)H nuclear magnetic resonance spectroscopic analysis for determination of glucuronic and iduronic acids in dermatan sulfate, heparin, and heparan sulfate.
    Sudo M; Sato K; Chaidedgumjorn A; Toyoda H; Toida T; Imanari T
    Anal Biochem; 2001 Oct; 297(1):42-51. PubMed ID: 11567526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analytical method for the determination of disaccharides derived from keratan, heparan, and dermatan sulfates in human serum and plasma by high-performance liquid chromatography/turbo ionspray ionization tandem mass spectrometry.
    Oguma T; Tomatsu S; Montano AM; Okazaki O
    Anal Biochem; 2007 Sep; 368(1):79-86. PubMed ID: 17603992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sulfotransferases and sulfated oligosaccharides.
    Honke K; Taniguchi N
    Med Res Rev; 2002 Nov; 22(6):637-54. PubMed ID: 12369092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N-acetylglucosamine 6-sulfate residues in keratan sulfate and heparan sulfate are desulfated by the same enzyme.
    Hopwood JJ; Elliott H
    Biochem Int; 1983 Feb; 6(2):141-8. PubMed ID: 6236815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural investigation of chondroitin/dermatan sulfate oligosaccharides from human skin fibroblast decorin.
    Zamfir A; Seidler DG; Kresse H; Peter-Katalinić J
    Glycobiology; 2003 Nov; 13(11):733-42. PubMed ID: 12799343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microanalysis of glycosaminoglycan-derived oligosaccharides labeled with a fluorophore 2-aminobenzamide by high-performance liquid chromatography: application to disaccharide composition analysis and exosequencing of oligosaccharides.
    Kinoshita A; Sugahara K
    Anal Biochem; 1999 May; 269(2):367-78. PubMed ID: 10222012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequence analysis of heparan sulphate and heparin oligosaccharides.
    Vivès RR; Pye DA; Salmivirta M; Hopwood JJ; Lindahl U; Gallagher JT
    Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):767-73. PubMed ID: 10215618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distribution of Heparan Sulfate Oligosaccharides in Murine Mucopolysaccharidosis Type IIIA.
    Mason K; Meikle P; Hopwood J; Fuller M
    Metabolites; 2014 Dec; 4(4):1088-100. PubMed ID: 25513953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combining size-exclusion chromatography and fully automated chip-based nanoelectrospray quadrupole time-of-flight tandem mass spectrometry for structural analysis of chondroitin/dermatan sulfate in human decorin.
    Zamfir AD; Flangea C; Sisu E; Seidler DG; Peter-Katalinić J
    Electrophoresis; 2011 Jun; 32(13):1639-46. PubMed ID: 21647927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Newborn screening and diagnosis of mucopolysaccharidoses.
    Tomatsu S; Fujii T; Fukushi M; Oguma T; Shimada T; Maeda M; Kida K; Shibata Y; Futatsumori H; Montaño AM; Mason RW; Yamaguchi S; Suzuki Y; Orii T
    Mol Genet Metab; 2013; 110(1-2):42-53. PubMed ID: 23860310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two-dimensional NMR spectroscopy of urinary glycosaminoglycans from patients with different mucopolysaccharidoses.
    Hochuli M; Wüthrich K; Steinmann B
    NMR Biomed; 2003 Jun; 16(4):224-36. PubMed ID: 14558120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of oligosaccharides from the chondroitin/dermatan sulfates. 1H-NMR and 13C-NMR studies of reduced trisaccharides and hexasaccharides.
    Huckerby TN; Nieduszynski IA; Giannopoulos M; Weeks SD; Sadler IH; Lauder RM
    FEBS J; 2005 Dec; 272(24):6276-86. PubMed ID: 16336265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dermatan sulfate and heparan sulfate as a biomarker for mucopolysaccharidosis I.
    Tomatsu S; Montaño AM; Oguma T; Dung VC; Oikawa H; de Carvalho TG; Gutiérrez ML; Yamaguchi S; Suzuki Y; Fukushi M; Sakura N; Barrera L; Kida K; Kubota M; Orii T
    J Inherit Metab Dis; 2010 Apr; 33(2):141-50. PubMed ID: 20162367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure of the asparagine-linked sugar chains of porcine kidney and human urine cerebroside sulfate activator protein.
    Faull KF; Johnson J; Kim MJ; To T; Whitelegge JP; Stevens RL; Fluharty CB; Fluharty AL
    J Mass Spectrom; 2000 Dec; 35(12):1416-24. PubMed ID: 11180632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glycosaminoglycan fragments as a measure of disease burden in the mucopolysaccharidosis type I mouse.
    Saville JT; McDermott BK; Fuller M
    Mol Genet Metab; 2018 Feb; 123(2):112-117. PubMed ID: 29273385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.